表紙
市場調查報告書
商品編碼
974407

醫藥品的再生醫療:各主題調查

Regenerative Medicine in Pharma - Thematic Research

出版日期: | 出版商: GlobalData | 英文 156 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

儘管普遍認為基因治療是最有益的再生醫療領域,不過,這個市場還有治療的成本高,存取受到限制的可能性,預計速度減低。

現有的計劃促進再生醫療的認證與開發,尤其是治療的償付系統受到保證。

本報告提供醫藥品的再生醫療的相關調查,主要趨勢,創新的產品及技術,市場區隔,及有影響未來的全球再生醫療市場的可能性的企業等相關分析。

目錄

  • 摘要整理
  • 再生醫療概要
  • 趨勢
  • 價值鏈
  • 市售產品
  • 開發中產品
  • 市場分析與交易
  • 企業
  • 法規及市場進入
  • 市場機會,課題,及未滿足需求

附錄

  • 諮詢方式
目錄
Product Code: GDHCHT211

Regenerative medicine is a multidisciplinary field that seeks to develop the science and tools that can help repair, augment, replace, or regenerate damaged or diseased human cells, tissues, genes, organs, or metabolic processes, to restore normal function. It may involve the transplantation of stem cells, progenitor cells, or tissue, stimulation of the body's own repair mechanisms, or the use of cells as delivery vehicles for therapeutic agents such as genes and cytokines.

It is widely anticipated that Gene therapy is the most valuable regenerative medicine sector however, this market is also expected to be slowed down by high cost of therapies, which may limit its accessibility.

Existing programs will facilitate the approval and development of regenerative medicines, however, a reimbursement system especially for curative therapies is warranted.

GlobalData's Regenerative Medicine in Pharma report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.

This report assesses -

  • Physician perceptions on Regenerative Medicine usage in clinical practice in the US, 5EU (France, Germany, Italy, Spain, and the UK), Japan and South Korea.
  • Regenerative Medicine Marketed and Pipeline products.
  • Opportunities and Challenges
  • Market analysis and Forecast
  • Unmet Needs
  • Regulation and Market Access
  • The report combines information obtained from secondary sources and primary research with specialists and physicians from different therapy areas (oncology, cardiology, and ophthalmology).

Scope

  • Components of the slide deck include primary and secondary research:
  • Quotes from key opinion leaders and payers
  • Summary of Regenerative Medicine product definitions and classifications
  • Overview of key Regenerative Medicine marketed products and key pipeline Regenerative Medicine products
  • Trends in Regenerative Medicine market
  • Call-outs of key information and details
  • Insight from GlobalData's specialist healthcare analysts

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Regenerative Medicine market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Regenerative Medicine market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Table of Contents

  • Executive Summary
  • Regenerative Medicine Overview
  • Trends
  • Value Chain
  • Marketed Products
  • Pipeline Products
  • Market Analysis and Deals
  • Companies
  • Regulatory and Market Access
  • Opportunities, Challenges, and Unmet Needs

Appendix

  • Contact Us